|
US7196055B2
(en)
*
|
1994-08-31 |
2007-03-27 |
Trustees Of Boston University |
Inhibition of apoptosis in keratinocytes by a ligand of p75 nerve growth factor receptor
|
|
US6867179B1
(en)
|
1994-08-31 |
2005-03-15 |
Trustees Of Boston University |
Methods of inducing hair growth and coloration
|
|
WO1997037228A1
(en)
*
|
1996-03-29 |
1997-10-09 |
The Trustees Of Boston University |
Methods for diagnosing and treating alzheimer's disease
|
|
HUP0202512A2
(hu)
*
|
1999-08-09 |
2002-11-28 |
Tripep Ab |
Fehérjék polimerizációját gátló anyagok és eljárások ezek alkalmazására
|
|
US6258932B1
(en)
*
|
1999-08-09 |
2001-07-10 |
Tripep Ab |
Peptides that block viral infectivity and methods of use thereof
|
|
KR20020007432A
(ko)
*
|
2000-07-13 |
2002-01-29 |
박현석 |
멜라노트랜스페린에 대한 단클론 항체를 유효성분으로포함하는 알츠하이머병의 진단시약
|
|
US6593455B2
(en)
*
|
2001-08-24 |
2003-07-15 |
Tripep Ab |
Tripeptide amides that block viral infectivity and methods of use thereof
|
|
US6455670B1
(en)
*
|
2001-09-06 |
2002-09-24 |
Tripep Ab |
Pentamer peptide amide, ALGPG-NH2, that inhibits viral infectivity and methods of use thereof
|
|
WO2003024995A1
(en)
*
|
2001-09-19 |
2003-03-27 |
Tripep Ab |
Molecules that block viral infectivity and methods of use thereof
|
|
AUPS230702A0
(en)
*
|
2002-05-14 |
2002-06-13 |
Walter And Eliza Hall Institute Of Medical Research, The |
A method of treatment
|
|
AU2004212786A1
(en)
*
|
2003-02-21 |
2004-09-02 |
Tripep Ab |
Glycinamide derivative for inhibiting HIV replication
|
|
US20050096319A1
(en)
*
|
2003-02-21 |
2005-05-05 |
Balzarini Jan M.R. |
Identification of compounds that inhibit replication of human immunodeficiency virus
|
|
JP2007528202A
(ja)
*
|
2003-03-28 |
2007-10-11 |
株式会社インテレクチャル・プロパティ・コンサルティング |
神経再生のための組成物および方法
|
|
ATE350389T1
(de)
|
2003-05-08 |
2007-01-15 |
Pentapharm Ag |
Tripeptide und deren derivate für die kosmetische verwendung zur verbesserung der hautstruktur
|
|
WO2005122712A2
(en)
*
|
2003-06-11 |
2005-12-29 |
Socratech L.L.C. |
Soluble low-density lipoprotein receptor related protein binds directly to alzheimer’s amyloid-beta peptide
|
|
EP1500399A1
(en)
*
|
2003-07-24 |
2005-01-26 |
Institut Pasteur |
Active or passive immunization against proapoptotic neurotrophins for the treatment or prevention of neurodegenerative deseases
|
|
US20110230479A1
(en)
*
|
2005-04-15 |
2011-09-22 |
Longo Frank M |
Neurotrophin mimetics and uses thereof
|
|
EP2594318B1
(en)
*
|
2005-04-15 |
2020-06-10 |
University Of North Carolina At Chapel Hill |
Methods of facilitating cell survival using neurotrophin mimetics
|
|
US8110672B2
(en)
*
|
2005-04-27 |
2012-02-07 |
Massachusetts Institute Of Technology |
Promoter engineering and genetic control
|
|
JPWO2008050754A1
(ja)
*
|
2006-10-23 |
2010-02-25 |
国立大学法人名古屋大学 |
脳内酸化抑制剤およびその使用
|
|
EP2376120A2
(en)
|
2008-11-25 |
2011-10-19 |
Biogen Idec MA Inc. |
Use of dr6 and p75 antagonists to promote survival of cells of the nervous system
|
|
TW201034684A
(en)
*
|
2009-02-18 |
2010-10-01 |
Genentech Inc |
Method for inhibiting neurodegeneration
|
|
US9458427B2
(en)
*
|
2009-08-07 |
2016-10-04 |
Case Western Reserve University |
IFNγR2 compositions and methods of inhibiting neuronal cell death
|
|
JP2013510871A
(ja)
*
|
2009-11-12 |
2013-03-28 |
ジェネンテック， インコーポレイテッド |
樹状突起棘の密度を促す方法
|
|
US10273219B2
(en)
|
2009-11-12 |
2019-04-30 |
Pharmatrophix, Inc. |
Crystalline forms of neurotrophin mimetic compounds and their salts
|
|
WO2011060262A1
(en)
|
2009-11-12 |
2011-05-19 |
Pharmatrophix, Inc. |
Crystalline forms of neurotrophin mimetic compounds and their salts
|
|
AU2013205000B2
(en)
*
|
2010-03-03 |
2015-05-28 |
The University Of British Columbia |
Oligomer-specific amyloid beta epitope and antibodies
|
|
EP2542571B1
(en)
*
|
2010-03-03 |
2016-05-25 |
The University of British Columbia |
Oligomer-specific amyloid beta epitope and antibodies
|
|
ES2628596T3
(es)
|
2010-11-29 |
2017-08-03 |
Akershus Universitetssykehus |
Procedimientos y composiciones para monitorizar la actividad fagocítica
|
|
JP2014528247A
(ja)
*
|
2011-10-05 |
2014-10-27 |
ブランシェット・ロックフェラー・ニューロサイエンスィズ・インスティテュート |
神経変性状態の刺激誘発性ゲノムプロファイルマーカー
|
|
WO2013082045A1
(en)
*
|
2011-11-28 |
2013-06-06 |
Buck Institute For Age Research |
Netrin loop peptide mimetics and uses thereof
|
|
GB2516045A
(en)
*
|
2013-07-09 |
2015-01-14 |
Neuro Bio Ltd |
Neurodegenerative disorders
|
|
ES2699410T3
(es)
*
|
2014-05-28 |
2019-02-11 |
Univ Dresden Tech |
Ensayo basado en células y métodos de cribado de moduladores de la señalización de p75NTR
|
|
WO2018161211A1
(en)
*
|
2017-03-06 |
2018-09-13 |
Nippon Zoki Pharmaceutical Co., Ltd. |
INHIBITING OR ALLEVIATING AGENT FOR Aβ-INDUCED DAMAGE
|
|
AU2018308088B2
(en)
|
2017-07-25 |
2025-05-29 |
Truebinding, Inc. |
Treating cancer by blocking the interaction of TIM-3 and its ligand
|
|
JP6359160B2
(ja)
*
|
2017-07-25 |
2018-07-18 |
株式会社Ｍｃｂｉ |
認知機能障害疾患のバイオマーカーおよび該バイオマーカーを用いる認知機能障害疾患の検出方法
|
|
CA3127113A1
(en)
|
2019-01-30 |
2020-08-06 |
Dongxu Sun |
Anti-gal3 antibodies and uses thereof
|
|
AU2021278935A1
(en)
|
2020-05-26 |
2022-12-08 |
Truebinding, Inc. |
Methods of treating inflammatory diseases by blocking Galectin-3
|
|
CN119661638B
(zh)
*
|
2024-11-22 |
2025-07-18 |
象山县第一人民医院医疗健康集团(宁波市第四医院、宁波市第四医院医院管理研究所) |
一种修复神经损伤的多肽、制备方法及其应用
|